A leading private equity player

The power of and

Companies must face multiple challenges to innovate, grow and adapt to a rapidly changing environment. It has been Andera Partners’ mission for over 20 years to help companies and their management achieve strong and sustainable growth. Our conviction, at the heart of our commitment, our partnership and our way to work with entrepreneurs, is that to grow and develop, it is essential to have the right partners and enjoy working together. The Power of And thus becomes Andera Partners’ signature that relays our conviction.

Our commitments Our investments

3,2 billion under management

265 companies supported for 25 years

90 professionals

Our Activities

Andera Partners is an asset management firm specialising in Private Equity. We draw on our expertise in various areas to provide a range of well-defined investment strategies. Our goal is to provide bespoke solutions to meet the challenges faced by leaders and their development models.

Our activities

Our Latest News

Below you will find all the latest news on Andera Partners, its teams and its investments.

19.01.2022 - andera Life Sciences - Press releases

JenaValve Announces Strategic Investment and Licensing Agreement with Peijia Medical Limited

Combined Shape

13.01.2022 - andera Life Sciences - Press releases

Allecra Therapeutics and ADVANZ PHARMA Sign Exclusive License and Supply Agreement for Allecra’s Ant…

Combined Shape

10.01.2022 - andera Life Sciences - Press releases

BioNTech and Crescendo Biologics announce global collaboration to develop multi-specific precision i…

Combined Shape

09.12.2021 - andera Infra - Press releases

Andera Partners announces 1st closing at €84m for Andera Smart Infra 1

Combined Shape

22.11.2021 - andera Life Sciences - Press releases

Vifor Pharma to acquire Sanifit to further strengthen late-stage pipeline in nephrology

Combined Shape

15.11.2021 - andera Acto - Press releases

Andera Partners supports the Founder of ENACO Group in the acquisition of its entire share capital a…

Combined Shape

28.10.2021 - andera Life Sciences - Press releases

Agomab Therapeutics to Acquire Origo Biopharma

Combined Shape

26.10.2021 - andera Life Sciences - Press releases

Andera Partners supports Exciva in a Series A to fight Alzheimer’s disease

Combined Shape

29.09.2021 - Andera Partners - Publications

The role of private equity in the recovery in France and Europe: an opportunity for investors

Combined Shape

16.09.2021 - andera Life Sciences - Press releases

Andera Partners leads Amolyt Pharma’s $80 million Series B alongside Sectoral Asset Management

Combined Shape

10.09.2021 - andera Acto - Press releases

Andera Acto supports DP Software Group in its development strategy

Combined Shape

09.09.2021 - andera Life Sciences - Press releases

Andera Partners leads US$ 83 million series A round in Evommune Inc. for the development of transfor…

Combined Shape

08.09.2021 - Andera Partners - Press releases

Andera Partners strengthens its investment teams and reaffirms its growth ambition

Combined Shape

02.08.2021 - andera Life Sciences - Press releases

T-knife Announces $110 Million Series B Financing to Advance Pipeline of T-cell Receptor Therapies

Combined Shape

27.07.2021 - andera Life Sciences - Press releases

Artios Pharma has completed a $153 million series C

Combined Shape
Our Latest News